Serum Vitamin D Status and Breast Cancer Risk by Receptor Status: A Systematic Review.

Nutrition and Cancer
Jessica L TommieLaurie A Nommsen-Rivers

Abstract

The association between vitamin D status and breast cancer risk is equivocal. No systematic reviews or meta-analyses have examined this association stratified by receptor status. Our objective is to conduct a systematic review to answer the question, "Is there a relationship between lower serum/plasma vitamin D levels and increased risk of triple negative breast cancer (TNBC) specifically?" We systematically searched Embase and PubMed databases for published original research studies examining the risk of a breast cancer diagnosis according to vitamin D status. We excluded studies that did not provide risk estimates stratified by receptor status. Fourteen studies met our criteria, including case-control, nested case-control, and case-series studies, reflecting the cumulative results of 13,135 breast cancer cases. When grouped by relevancy to TNBC, the proportion of analyses across all study types showing a significant association between vitamin D status and breast cancer diagnosis was 37% for non-TNBC analyses, 48% for analyses that included some TNBC cases, and 88% for TNBC analyses. Our results suggest that low vitamin D status may particularly increase the risk of TNBC, although more research is needed to determine if this ...Continue Reading

References

Oct 8, 2008·International Journal of Cancer. Journal International Du Cancer·Sascha AbbasJakob Linseisen
May 28, 2009·Cancer Prevention Research·Katherine D CrewRegina M Santella
Oct 1, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Lars RejnmarkLeif Mosekilde
Feb 12, 2011·Nutrition Research·Kimberly Y Z Forrest, Wendy L Stuhldreher
May 17, 2011·Breast Cancer Research : BCR·A Heather EliassenSusan E Hankinson
Jun 29, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A GoldhirschUNKNOWN Panel members
Oct 21, 2011·The Journal of Clinical Endocrinology and Metabolism·G LensmeyerN Binkley
Mar 27, 2012·Annals of Surgical Oncology·Luke J PepponeKristin A Skinner
Jun 9, 2012·Breast Cancer Research : BCR·Nair LopesFernando Schmitt
Aug 29, 2012·Steroids·Marcel J W JanssenJohannes M W van den Ouweland
Feb 28, 2013·Breast Cancer Research : BCR·Stephanie ScarmoAnne Zeleniuch-Jacquotte
Mar 26, 2013·International Journal of Cancer. Journal International Du Cancer·Tilman KühnJakob Linseisen
Jun 29, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Dan WangDian-Wu Liu
Dec 3, 2014·The Journal of Steroid Biochemistry and Molecular Biology·Jae Young So, Nanjoo Suh
Apr 25, 2015·The Oncologist·Maggie C U CheangLisa A Carey
Jun 5, 2015·British Journal of Pharmacology·Vinayak S JamdadeNeeraj Sinha
Aug 9, 2015·The Breast : Official Journal of the European Society of Mastology·Aleix PratMontserrat Muñoz
Oct 30, 2015·CA: a Cancer Journal for Clinicians·Carol E DeSantisAhmedin Jemal
Nov 12, 2015·The Journal of Steroid Biochemistry and Molecular Biology·Omalkhair AbulkhairHana M Fakhoury
Jun 22, 2016·The Breast : Official Journal of the European Society of Mastology·L ShiraziJ Manjer
Aug 18, 2016·Cancer Research·A Heather EliassenSusan E Hankinson
Apr 12, 2017·Seminars in Oncology·Kimberly S PeairsHeather F Sateia

❮ Previous
Next ❯

Citations

Sep 9, 2020·Environmental Health Perspectives·Lindsey Konkel
Jan 7, 2020·Environmental Health Perspectives·Troy W R HillerWill D King
May 28, 2020·International Journal of Molecular Sciences·Janusz BlasiakCezary Chojnacki
Dec 2, 2020·Molecular Biology Reports·Ioannis A Voutsadakis
Aug 24, 2019·Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN·Marit L Bovbjerg, Sabrina Pillai
Oct 2, 2020·Hematology/oncology and Stem Cell Therapy·Ioannis A Voutsadakis
Jul 11, 2021·Cancer Prevention Research·Sarah M BernhardtPepper Schedin

❮ Previous
Next ❯

Methods Mentioned

BETA
blood draw
blood collection
hormone replacement therapy

Software Mentioned

PRISMA

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Yanlei MaHuanlong Qin
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences
Nahid Ramezani JolfaieLeila Azadbakht
© 2022 Meta ULC. All rights reserved